Celyad Oncology SA (1C0.MU) Q3 2026 Earnings

23SepConfirmed
Q2 2024
-0.79
-0.46
-0.13
0.21

Details

Expected EPS
N/A
Actual EPS
N/A
Surprise EPS
0
Surprise Percent
+NaN%

Description

Celyad Oncology SA (1C0.MU) will report earnings of for Q3 2026 on September 23, 2026.

0 Comments

Share your thoughts